North America Scar Treatment Market Growth Accelerated By Scar Treatment Gaining Preference For Post Traumatic Scar Management
![]() |
Scar treatment products includes scar gel, scar sheets, patches, creams etc which helps in fading scars, redness and restoring skin texture. These products are clinically proven to reduce the appearance of scars like acne, post-surgical, burns etc by speeding up skin renewal process, managing scar formation and inflammation.
The
global North America scar treatment market is estimated to be valued at US$ 4,348.7 million in 2023 and is
expected to exhibit a CAGR of 4.3%
over the forecast period 2023-2030,
as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Scar treatment gaining preference for post
traumatic scar management has been one key trend contributing to market growth.
Various traumatic injuries and incidents leading to scarring has fueled the
demand for scar treatments. Also, increasing awareness about new scar treatment
products and their efficacy in scar reduction has accelerated their adoption.
Growing preference for minimally invasive procedures and topical scar
treatments over surgical procedures for scar management, has boosted the North
America scar treatment market.
Segment
Analysis
The North America scar treatment market is dominated by the prescription scar
treatment sub-segment. This sub-segment currently holds the largest market
share due to the availability of US Food and Drug Administration (FDA) approved
prescription products and increasing awareness about their efficacy in treating
scars. Topical medications such as creams, gels, and lotions are extensively
prescribed by dermatologists and other healthcare professionals for the treatment
of scars like hypertrophic and keloid scars.
Key Takeaways
The Global
North America Scar Treatment Market Size
is expected to witness high growth over the forecast period of 2023
to 2030. The global North America Scar Treatment Market is estimated to be
valued at US$ 4,348.7 Mn in 2023 and is expected to exhibit a CAGR of 4.3% over
the forecast period 2023-2030.
Regional analysis
The United States holds the dominant share in the North American scar treatment
market and is expected to witness the fastest growth during the forecast
period. This is attributed to the presence of major market players, high
healthcare expenditure, and rising awareness about scar treatment options in
the country. Canada is also projected to exhibit lucrative growth prospects due
to the increasing adoption of novel scar treatment technologies across medical
facilities.
Key players
Key players operating in the North America scar treatment market are ScarAway,
Thrive Aesthetics MN, HRA Pharma, MARLO WHITNEY, Smith & Nephew Inc, Merz
Therapeutics, Enaltus LLC, Oculus Innovative Sciences, Inc, CCA Industries,
Bausch Health Companies Inc., Candela Medical, Perrigo Company plc, Sonoma
Pharmaceuticals, Inc., Hologic, Inc., Johnson & Johnson Surface Treatment,
Inc., Quantum Health, AVITA Medical, Revitol Corp, Scarguard labs, Lumenis Be
Ltd, Cynosure, GC Aesthetics, Sientra, Inc, SkinCeuticals, Cimeosil.com,
Honeydew Products, 3V Sigma USA Inc., Syneron Medical Ltd.
Get
more insights on this topic:
Comments
Post a Comment